ATRA
Price
$10.88
Change
-$0.07 (-0.64%)
Updated
Aug 11, 11:55 AM (EDT)
Capitalization
65.31M
MOLN
Price
$3.45
Change
-$0.21 (-5.74%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
134.53M
14 days until earnings call
Interact to see
Advertisement

ATRA vs MOLN

Header iconATRA vs MOLN Comparison
Open Charts ATRA vs MOLNBanner chart's image
Atara Biotherapeutics
Price$10.88
Change-$0.07 (-0.64%)
Volume$200
Capitalization65.31M
Molecular Partners AG
Price$3.45
Change-$0.21 (-5.74%)
VolumeN/A
Capitalization134.53M
ATRA vs MOLN Comparison Chart in %
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. MOLN commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Hold and MOLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (ATRA: $10.95 vs. MOLN: $3.66)
Brand notoriety: ATRA and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 52% vs. MOLN: 81%
Market capitalization -- ATRA: $65.31M vs. MOLN: $134.53M
ATRA [@Biotechnology] is valued at $65.31M. MOLN’s [@Biotechnology] market capitalization is $134.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whileMOLN’s FA Score has 1 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • MOLN’s FA Score: 1 green, 4 red.
According to our system of comparison, MOLN is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 4 TA indicator(s) are bullish while MOLN’s TA Score has 4 bullish TA indicator(s).

  • ATRA’s TA Score: 4 bullish, 5 bearish.
  • MOLN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ATRA and MOLN are a bad buy in the short-term.

Price Growth

ATRA (@Biotechnology) experienced а -5.15% price change this week, while MOLN (@Biotechnology) price change was +3.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.72%. For the same industry, the average monthly price growth was +32.20%, and the average quarterly price growth was +19.30%.

Reported Earning Dates

MOLN is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+22.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($135M) has a higher market cap than ATRA($65.3M). ATRA YTD gains are higher at: -17.693 vs. MOLN (-22.810). ATRA has higher annual earnings (EBITDA): -5.74M vs. MOLN (-57.15M). MOLN has more cash in the bank: 131M vs. ATRA (13.8M). MOLN has less debt than ATRA: MOLN (2.14M) vs ATRA (40.6M). ATRA has higher revenues than MOLN: ATRA (200M) vs MOLN (2.23M).
ATRAMOLNATRA / MOLN
Capitalization65.3M135M48%
EBITDA-5.74M-57.15M10%
Gain YTD-17.693-22.81078%
P/E RatioN/AN/A-
Revenue200M2.23M8,961%
Total Cash13.8M131M11%
Total Debt40.6M2.14M1,896%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRAMOLN
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 21 days ago
83%
Bullish Trend 14 days ago
68%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNTMF0.070.01
+11.48%
FLUENT CORP
EWPMF0.03N/A
+0.36%
East West Petroleum Corp.
MDIBF23.15N/A
N/A
MedioBanca SpA
NENTF0.04N/A
N/A
Viaplay Group AB
SPASF2.50N/A
N/A
SATS Ltd.

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with GRI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
-0.05%
GRI - ATRA
40%
Loosely correlated
+0.80%
SLRX - ATRA
39%
Loosely correlated
-10.07%
FULC - ATRA
35%
Loosely correlated
-4.70%
FOLD - ATRA
34%
Loosely correlated
-0.44%
MOLN - ATRA
33%
Poorly correlated
N/A
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
N/A
SNSE - MOLN
42%
Loosely correlated
+6.10%
ATRA - MOLN
34%
Loosely correlated
-0.05%
HURA - MOLN
30%
Poorly correlated
-5.35%
GRI - MOLN
30%
Poorly correlated
+0.80%
GUTS - MOLN
29%
Poorly correlated
-1.16%
More